New Zealand markets close in 1 hour 4 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
286.36+16.94 (+6.29%)
At close: 4:00PM EDT
284.11 -2.25 (-0.79%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 563.32B
Enterprise value 362.56B
Trailing P/E 13.50
Forward P/E 15.45
PEG ratio (5-yr expected) 10.05
Price/sales (ttm)7.25
Price/book (mrq)9.45
Enterprise value/revenue 38.05
Enterprise value/EBITDA 710.94

Trading information

Stock price history

Beta (5Y monthly) -1.16
52-week change 3222.88%
S&P500 52-week change 331.29%
52-week high 3464.00
52-week low 375.35
50-day moving average 3298.05
200-day moving average 3254.65

Share statistics

Avg vol (3-month) 34.2M
Avg vol (10-day) 32.07M
Shares outstanding 5242.52M
Implied shares outstanding 6N/A
Float 877.79M
% held by insiders 11.15%
% held by institutions 116.61%
Shares short (29 Sep 2021) 42.29M
Short ratio (29 Sep 2021) 40.71
Short % of float (29 Sep 2021) 4N/A
Short % of shares outstanding (29 Sep 2021) 40.94%
Shares short (prior month 30 Aug 2021) 42.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 52.41%
Operating margin (ttm)71.20%

Management effectiveness

Return on assets (ttm)68.31%
Return on equity (ttm)133.85%

Income statement

Revenue (ttm)7.77B
Revenue per share (ttm)31.98
Quarterly revenue growth (yoy)12,630.20%
Gross profit (ttm)-222.04M
EBITDA 5.58B
Net income avi to common (ttm)4.07B
Diluted EPS (ttm)17.94
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)914.9M
Total cash per share (mrq)3.75
Total debt (mrq)256.8M
Total debt/equity (mrq)4.68
Current ratio (mrq)2.67
Book value per share (mrq)22.47

Cash flow statement

Operating cash flow (ttm)-354.87M
Levered free cash flow (ttm)-1.08B